A special committee at Hudson’s Bay rejected an offer by private-equity firm Catalyst Capital that values the Canadian retailer at more than CA$2 billion (US$1.5 billion), giving the upper hand to a lower bid by the company’s chairman.
The offer presented last week by Catalyst is “not reasonably capable of being consummated,” the committee said in a statement late Monday, December 2. Catalyst’s proposal of CA$11 a share represented a 6.8% premium to the CA$10.30 a share that Hudson’s Bay Chairman Richard Baker and his partners agreed to pay in October, and which the committee and the board backed.
Baker and his allies confirmed that they weren’t interested in any transaction that would result in the sale of their interest in Hudson’s Bay, the committee said in its statement. Since the group owns 57%, and the Catalyst offer requires at least three-quarters of votes, it means the transaction can’t be completed, the committee said.
According to Bloomberg, the response is the latest twist in the battle for the struggling retailer, which Baker said he wants to turn around outside the glare of public markets. The rivalry next moves to December 17, when shareholders are set to vote on Baker’s offer.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI